Chart calendar RXi Pharmaceuticals Corp
Upcoming events on RXi Pharmaceuticals Corp
Past events on RXi Pharmaceuticals Corp
2024-03-26 | Q4 2023 Earnings Release (Projected) |
2024-03-22 01:00 pm | Immunotherapy of Cancer Conference |
2024-03-21 01:00 pm | Immunotherapy of Cancer Conference |
2024-03-21 01:00 pm | Immunotherapy of Cancer Conference - Poster No : P01.03 |
2023-11-09 04:30 pm | Q3 2023 Earnings Release |
2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number : 474 |
2023-10-14 12:30 pm | AACR NCI EORTC International Conference - INTASYL™ self-delivering RNAi therapeutic targeting BRD4 e |
2023-10-14 12:30 pm | AACR NCI EORTC International Conference - INTASYL™ PH-894 self-delivering RNAi targeting BRD4 |
2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
2023-08-10 04:30 pm | Q2 2023 Earnings Release |
2023-07-20 09:00 am | Annual General Meeting |
2023-05-17 03:00 pm | American Society of Gene & Cell Therapy Meeting - Abstract No: 544 |
2023-05-11 05:00 pm | Q1 2023 Earnings Release |
2023-04-18 01:30 pm | American Association for Cancer Research Meeting |
2023-04-17 09:00 am | American Association for Cancer Research Meeting - Intratumoral PH-762 |
2023-03-22 05:05 pm | Q4 2022 Earnings Release |
2023-01-25 | Reverse Split: 1 of 12 |
2023-01-07 | Dermatology Summit |
2022-11-11 09:00 am | Society for Immunotherapy of Cancer Meeting - Abstract #: 1402 |
2022-11-11 09:00 am | Society for Immunotherapy of Cancer Meeting - Abstract #:788 |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,14 0,10 38% | 0,02 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | -7,36 -7,60 3.11% | -8,99 -8,60 -4.5% | -8,79 -8,80 0.08% | -13,5 -14,4 6.17% | -11,5 -12,4 7.56% | -12,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,36 -7,60 3.16% | -8,91 -8,50 -4.8% | -8,79 -8,80 0.07% | -13,3 -14,2 6.43% | -11,5 -12,4 7.42% | -12,0 |
Net income Million USD | Released Forecast Spread | -7,36 -7,60 3.16% | -8,91 -8,50 -4.8% | -8,79 -8,80 0.07% | -13,3 -14,2 6.43% | -11,5 -12,4 7.42% | -12,0 |
EPS USD | Released Forecast Spread | -686 -1 195 42.54% | -232 -224 -3.37% | -23,0 -23,0 0% | -12,5 -13,3 6.31% | -10,1 -10,9 7.51% | -6,26 |
Announcement Date | 27/03/19 | 26/03/20 | 25/03/21 | 22/03/22 | 22/03/23 | - |
Quarterly results
Fiscal Period | December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 12,5 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | |
EBIT Million USD | Released Forecast Spread | -3,74 -3,40 -9.97% | -3,45 -4,40 21.59% | -2,64 -4,10 35.61% | -2,52 -4,10 38.51% | -3,57 9,90 -136.07% | -2,73 -3,70 26.22% | -2,78 -2,80 0.86% | -3,10 | |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,74 -3,40 -10.06% | -3,45 -4,40 21.57% | -2,64 -4,10 35.56% | -2,53 -4,10 38.27% | -3,58 9,90 -136.12% | -2,73 -3,70 26.19% | -2,78 -2,80 0.71% | -3,10 | |
Net income Million USD | Released Forecast Spread | -3,74 -3,40 -10.06% | -3,45 -4,40 21.57% | -2,64 -4,10 35.56% | -2,53 -4,10 38.27% | -3,58 7,50 -147.68% | -2,73 -3,70 26.19% | -2,55 | -2,78 -2,80 0.71% | -3,10 |
EPS USD | Released Forecast Spread | -3,36 -3,00 -12% | -3,12 -3,84 18.75% | -2,28 -3,60 36.67% | -2,28 -3,72 38.71% | -3,12 4,32 -172.22% | -2,42 -3,24 25.31% | -1,47 | -1,14 -1,43 20.28% | -1,30 |
Announcement Date | 10/11/21 | 22/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 22/03/23 | 10/08/23 | 09/11/23 | - |
Past sector events for RXi Pharmaceuticals Corp
2024-03-28 04:28 pm | CENTESSA PHARMACEUTICALS PLC: Q4 2023 Earnings Release |
2024-03-28 04:05 pm | ARRIVENT BIOPHARMA, INC.: Q4 2023 Earnings Release |
2024-03-27 | SAB BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release (Projected) |
2024-03-27 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q4 2023 Earnings Release |
2024-03-27 | HANGZHOU TIGERMED CONSULTING CO., LTD: Q4 2023 Earnings Release |
2024-03-27 | ALPHAMAB ONCOLOGY: Q4 2023 Earnings Release |
2024-03-26 | PHARMARON BEIJING CO., LTD.: Q4 2023 Earnings Release |
2024-03-26 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q4 2023 Earnings Release |
2024-03-26 04:01 pm | KORRO BIO, INC.: Q4 2023 Earnings Release |
2024-03-26 06:00 am | GYRE THERAPEUTICS, INC.: Q4 2023 Earnings Release |